Case Report: Avoidance of Palpable Corporal Fibrosis Due to Priapism with Upregulators of Nitric Oxide

Authors

  • Jacob Rajfer MD,

    1. Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA;
    Search for more papers by this author
  • John L. Gore MD,

    Corresponding author
    1. Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA;
      John Gore, MD, David Geffen School of Medicine, University of California, Los Angeles––Urology, Box 951738, CHS Rm 66-124, 10833 LeConte Ave, Los Angeles, CA 90095-1738, USA. Tel: (310) 206-0473; Fax: (310) 206-5343; E-mail: jgore@mednet.ucla.edu
    Search for more papers by this author
  • Jeffrey Kaufman MD,

    1. Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA;
    Search for more papers by this author
  • Nestor Gonzalez-Cadavid PhD

    1. Research and Education Institute, Harbor-UCLA, Los Angeles, CA, USA
    Search for more papers by this author

John Gore, MD, David Geffen School of Medicine, University of California, Los Angeles––Urology, Box 951738, CHS Rm 66-124, 10833 LeConte Ave, Los Angeles, CA 90095-1738, USA. Tel: (310) 206-0473; Fax: (310) 206-5343; E-mail: jgore@mednet.ucla.edu

ABSTRACT

Introduction.  Recent evidence suggests that blocking inducible nitric oxide (NO) synthase in the penis may exacerbate fibrotic processes and that application of medications known to increase NO in tissues may prevent fibrosis.

Aim.  To report the use of an antifibrotic regimen consisting of medications known to upregulate NO production in two patients with refractory priapism.

Methods.  Two patients presented with priapism of greater than 48-hour duration. After corporal aspiration/irrigation and shunting procedures failed, both were prescribed a daily antifibrotic regimen comprising the phosphodiesterase inhibitors pentoxifylline and sildenafil, and the NO precursor, l-arginine.

Results.  At 1 year, both patients were found to have supple corpora without evidence of corporal fibrosis.

Conclusions.  An antifibrotic regimen consisting of upregulators of NO production may ameliorate the corporal fibrosis associated with recalcitrant priapism. Rajfer J, Gore JL, Kaufman J, and Gonzalez-Cadavid N. Case report: Avoidance of palpable corporal fibrosis due to priapism with upregulators of nitric oxide. J Sex Med 2006;3:173–176.

Ancillary